We describe the first example of an inhibitory antibody fragment (nanobody ca1697) that binds simultaneously to an enzyme (the enzyme dihydrofolate reductase from <i>Escherichia coli</i>) and its bound substrate (folate). Binding of the antibody to the substrate causes a 20-fold reduction in the rate of folate exchange kinetics. This work opens up the prospect of designing new types of antibody-based inhibitors of enzymes and receptors through suitable design of immunogens
AbstractBackground: Enzymes have evolved to recognise their target substrates with exquisite selecti...
Allosteric control of enzyme activity with exogenous substances has been hard to achieve, especially...
AbstractPolyclonal antibodies raised against isolated subunit V from beef heart cytochrome oxidase o...
Antibodies have transformed biomedical research and are now being used for different experimental ap...
Research concerning the feasibility of replacing antibodies with binding proteins as the specific bi...
A peptide segment that binds the active site of a serine protease in a substrate-like manner may beh...
Synthetic protein switches are proteins that can be controlled by an external input, and are useful ...
The relation between domain structures of recombinant monoclonal antibody fragments and their reacti...
253-258The idea that enzymes can be generated by employing antibodies complimentary to haptenic grou...
The relation between domain structures of recombinant monoclonal antibody fragments and their reacti...
Alpha folate receptor (FRα) is currently under investigation as a target for the treatment of patien...
Antibodies are immunoglobulins that bind to stable ground-state molecules and recognise their respec...
Antibodies, the cardinal effector molecules of the immune system, are being leveraged to enormous su...
Due to the conserved nature of protease active sites, it has been difficult to develop protease inhi...
International audienceFully functional variable fragments (Fv) of D1.3, a mouse antibody directed ag...
AbstractBackground: Enzymes have evolved to recognise their target substrates with exquisite selecti...
Allosteric control of enzyme activity with exogenous substances has been hard to achieve, especially...
AbstractPolyclonal antibodies raised against isolated subunit V from beef heart cytochrome oxidase o...
Antibodies have transformed biomedical research and are now being used for different experimental ap...
Research concerning the feasibility of replacing antibodies with binding proteins as the specific bi...
A peptide segment that binds the active site of a serine protease in a substrate-like manner may beh...
Synthetic protein switches are proteins that can be controlled by an external input, and are useful ...
The relation between domain structures of recombinant monoclonal antibody fragments and their reacti...
253-258The idea that enzymes can be generated by employing antibodies complimentary to haptenic grou...
The relation between domain structures of recombinant monoclonal antibody fragments and their reacti...
Alpha folate receptor (FRα) is currently under investigation as a target for the treatment of patien...
Antibodies are immunoglobulins that bind to stable ground-state molecules and recognise their respec...
Antibodies, the cardinal effector molecules of the immune system, are being leveraged to enormous su...
Due to the conserved nature of protease active sites, it has been difficult to develop protease inhi...
International audienceFully functional variable fragments (Fv) of D1.3, a mouse antibody directed ag...
AbstractBackground: Enzymes have evolved to recognise their target substrates with exquisite selecti...
Allosteric control of enzyme activity with exogenous substances has been hard to achieve, especially...
AbstractPolyclonal antibodies raised against isolated subunit V from beef heart cytochrome oxidase o...